Literature DB >> 8722842

Amphotericin B: a commentary on its role as an antifungal agent and as a comparative agent in clinical trials.

H A Gallis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8722842     DOI： 10.1093/clinids/22.supplement_2.s145

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  7 in total

Review 1.  Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis.

Authors:  A J Coukell; R N Brogden
Journal:  Drugs       Date:  1998-04       Impact factor: 9.546

2.  Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis.

Authors:  R Santangelo; P Paderu; G Delmas; Z W Chen; R Mannino; L Zarif; D S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

3.  In vitro and in vivo activities of posaconazole against Coccidioides immitis.

Authors:  Gloria M González; Rolando Tijerina; Laura K Najvar; Rosie Bocanegra; Michael Rinaldi; David Loebenberg; John R Graybill
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

Review 4.  Current and emerging azole antifungal agents.

Authors:  D J Sheehan; C A Hitchcock; C M Sibley
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

5.  Efficacies of amphotericin B (AMB) lipid complex, AMB colloidal dispersion, liposomal AMB, and conventional AMB in treatment of murine coccidioidomycosis.

Authors:  Gloria M González; Rolando Tijerina; Laura K Najvar; Rosie Bocanegra; Michael G Rinaldi; John R Graybill
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

Review 6.  Amphotericin-B colloidal dispersion. A review of its use against systemic fungal infections and visceral leishmaniasis.

Authors:  R N Brogden; K L Goa; A J Coukell
Journal:  Drugs       Date:  1998-09       Impact factor: 9.546

Review 7.  Antifungal pharmacodynamics: Latin America's perspective.

Authors:  Javier M Gonzalez; Carlos A Rodriguez; Maria Agudelo; Andres F Zuluaga; Omar Vesga
Journal:  Braz J Infect Dis       Date:  2016-11-05       Impact factor: 3.257
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.